Investors in Bio-Rad Laboratories (NYSE:BIO) have unfortunately lost 47% over the last five years [Yahoo! Finance]
Bio-Rad Laboratories, Inc. Class B (BIO.B)
US:NYSE Investor Relations:
bio-rad.com/en-us/corporate/investor-relations
Company Research
Source: Yahoo! Finance
NYSE:BIO ) share price up 12% in a single quarter. But over the last half decade, the stock has not performed well. You would have done a lot better buying an index fund, since the stock has dropped 47% in that half decade. So let's have a look and see if the longer term performance of the company has been in line with the underlying business' progress. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price. Bio-Rad Laboratories became profitable within the last five years. That would generally be considered a positive, so we are surprised to see the share price is down. Other metrics might give us a better handle on how its value is changing over ti
Show less
Read more
Impact Snapshot
Event Time:
BIO.B
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BIO.B alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIO.B alerts
High impacting Bio-Rad Laboratories, Inc. Class B news events
Weekly update
A roundup of the hottest topics
BIO.B
News
- A Look At The Intrinsic Value Of Bio-Rad Laboratories, Inc. (NYSE:BIO) [Yahoo! Finance]Yahoo! Finance
- Why Bio-Rad Laboratories Stock Slipped by More Than 3% on Thursday [Yahoo! Finance]Yahoo! Finance
- Vector Purification Research Report 2025-2035: 100+ Products, 1,000+ Clinical Trials and Rising Demand for Adenoviral and Lentiviral Therapies Drive Global Growth [Yahoo! Finance]Yahoo! Finance
- Bio-Rad Laboratories, Inc. Co-Founder and Director Emeritus Alice Schwartz Passes Away [Yahoo! Finance]Yahoo! Finance
- Non-Viral Transfection Reagents Market Industry Trends and Forecasts to 2035: Patents, Partnerships, and Big Pharma Initiatives Accelerate Non-Viral Transfection Reagents Market Growth [Yahoo! Finance]Yahoo! Finance